Correlation Between Coherus BioSciences and NextCure

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Coherus BioSciences and NextCure at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Coherus BioSciences and NextCure into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Coherus BioSciences and NextCure, you can compare the effects of market volatilities on Coherus BioSciences and NextCure and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Coherus BioSciences with a short position of NextCure. Check out your portfolio center. Please also check ongoing floating volatility patterns of Coherus BioSciences and NextCure.

Diversification Opportunities for Coherus BioSciences and NextCure

0.16
  Correlation Coefficient

Average diversification

The 3 months correlation between Coherus and NextCure is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Coherus BioSciences and NextCure in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NextCure and Coherus BioSciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Coherus BioSciences are associated (or correlated) with NextCure. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NextCure has no effect on the direction of Coherus BioSciences i.e., Coherus BioSciences and NextCure go up and down completely randomly.

Pair Corralation between Coherus BioSciences and NextCure

Given the investment horizon of 90 days Coherus BioSciences is expected to generate 2.07 times more return on investment than NextCure. However, Coherus BioSciences is 2.07 times more volatile than NextCure. It trades about 0.32 of its potential returns per unit of risk. NextCure is currently generating about -0.12 per unit of risk. If you would invest  72.00  in Coherus BioSciences on September 2, 2024 and sell it today you would earn a total of  50.00  from holding Coherus BioSciences or generate 69.44% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Coherus BioSciences  vs.  NextCure

 Performance 
       Timeline  
Coherus BioSciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Coherus BioSciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Coherus BioSciences is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
NextCure 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days NextCure has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Coherus BioSciences and NextCure Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Coherus BioSciences and NextCure

The main advantage of trading using opposite Coherus BioSciences and NextCure positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Coherus BioSciences position performs unexpectedly, NextCure can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NextCure will offset losses from the drop in NextCure's long position.
The idea behind Coherus BioSciences and NextCure pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Complementary Tools

Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance